Skip Navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Mutant p53 Activities in Mouse Tumor Models

Loading video...

308 Views

Air date: Wednesday, December 7, 2022, 3:00:00 PM
Time displayed is Eastern Time, Washington DC Local
Views: Total views: 308 (108 Live, 200 On-demand)
Category: WALS - Wednesday Afternoon Lectures
Runtime: 01:09:52
Description: NIH Director’s Wednesday Afternoon Lecture Series

Margaret Pittman Lecture

This is the annual WALS–Pittman lecture, but rescheduled from March 2022. Guillermina (Gigi) Lozano is a renowned geneticist recognized for her studies of the p53 tumor suppressor pathway. This pathway is undermined in a large percent of human cancers via mutations and deletions of p53. Her laboratory identified a transcriptional activation function for p53. Using mouse models, her team characterized the physiological importance of Mdm2 and Mdm4 proteins as potent inhibitors of p53. The Mdm proteins are over expressed in many cancers that lack p53 mutations presenting an alternate mechanism of eliminating p53 activity. Other mouse models inheriting the most common p53 mutations revealed gain-of-function phenotypes that drive metastases. Mutation of the p53 gene is a critical event in the elaboration of many tumors of diverse origin. The p53 protein is activated in response to DNA damage, serving as a checkpoint in the elimination or repair of cells with damaged DNA. Alterations in components of the p53 pathway, such as amplification of the Mdm2 gene, which encodes a p53 inhibitor, also contribute to tumorigenesis. The overall goal of my laboratory is to understand the signals that regulate the p53 pathway and the consequences of expressing wild-type or mutant p53.

For more information go to https://oir.nih.gov/wals
NLM Title: Mutant p53 activities in mouse tumor models / Guillermina Lozano.
Author: Lozano, Guillermina.
National Institutes of Health (U.S.),
Publisher:
Abstract: (CIT): NIH Director"s Wednesday Afternoon Lecture Series Margaret Pittman Lecture This is the annual WALS-Pittman lecture, but rescheduled from March 2022. Guillermina (Gigi) Lozano is a renowned geneticist recognized for her studies of the p53 tumor suppressor pathway. This pathway is undermined in a large percent of human cancers via mutations and deletions of p53. Her laboratory identified a transcriptional activation function for p53. Using mouse models, her team characterized the physiological importance of Mdm2 and Mdm4 proteins as potent inhibitors of p53. The Mdm proteins are over expressed in many cancers that lack p53 mutations presenting an alternate mechanism of eliminating p53 activity. Other mouse models inheriting the most common p53 mutations revealed gain-of-function phenotypes that drive metastases. Mutation of the p53 gene is a critical event in the elaboration of many tumors of diverse origin. The p53 protein is activated in response to DNA damage, serving as a checkpoint in the elimination or repair of cells with damaged DNA. Alterations in components of the p53 pathway, such as amplification of the Mdm2 gene, which encodes a p53 inhibitor, also contribute to tumorigenesis. The overall goal of my laboratory is to understand the signals that regulate the p53 pathway and the consequences of expressing wild-type or mutant p53. For more information go to https://oir.nih.gov/wals.
Subjects: Disease Models, Animal
Mice
Proto-Oncogene Proteins c-mdm2
Transcription Factors
Tumor Suppressor Protein p53--genetics
Publication Types: Lecture
Webcast
 
NLM Classification: QU 55.2
NLM ID: 9918573277006676
CIT Live ID: 46003
Permanent link: https://videocast.nih.gov/watch=46003

The server returned an invalid or unrecognized response